Battery innovation and the next wave of orthopaedic implants

Ilika Plc

Orthopaedic procedures today restore quality of life for millions each year, but failure rates remain a pressing issue. Infection, loosening, or mechanical collapse often reveal themselves only when pain returns, by which point revision surgery is the only option. The next generation of implants is being built to change that timeline entirely. By embedding sensors capable of measuring pressure, movement, and temperature, these devices can provide surgeons with a real-time window into the health of the joint.

Yet the ability to collect and send this information rests on a problem many overlook: powering the device without compromising its structural integrity. Conventional batteries are too bulky or unreliable to integrate safely into implants. This is where miniature solid state batteries enter the conversation. Designed at millimetre scale, they can be embedded within a prosthetic without weakening it, while still delivering the performance needed to drive sensors and communications.

Ilika’s Stereax M300, for instance, has been designed to address exactly these constraints. With a rectangular footprint just a few millimetres across, it offers the compactness necessary for true miniaturisation. Despite its size, it is capable of producing the pulse currents required for both sensing and wireless transmission. Equally important is the ability to recharge quickly and wirelessly, which not only ensures the longevity of the implant but also supports patient compliance by making at-home charging feasible and convenient.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika starts commercial supply to Cirtec

Ilika begins commercial delivery of Stereax electrodes under first supply order from Cirtec.

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Search

Search